ACADIA Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.

About ACAD

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. 

CEO
Catherine Owen Adams
CEOCatherine Owen Adams
Employees
654
Employees654
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1993
Founded1993
Employees
654
Employees654

ACAD Key Statistics

Market cap
3.57B
Market cap3.57B
Price-Earnings ratio
15.85
Price-Earnings ratio15.85
Dividend yield
Dividend yield
Average volume
1.58M
Average volume1.58M
High today
$22.21
High today$22.21
Low today
$21.04
Low today$21.04
Open price
$21.67
Open price$21.67
Volume
1.50M
Volume1.50M
52 Week high
$25.23
52 Week high$25.23
52 Week low
$13.40
52 Week low$13.40

ACAD News

Simply Wall St 7d
ACADIA Pharmaceuticals Inc. Surges 54% Yet Its Low P/S Is No Reason For Excitement

ACADIA Pharmaceuticals Inc. ( ) shares have had a really impressive month, gaining 54% after a shaky period beforehand. The last 30 days bring the annual gain t...

ACADIA Pharmaceuticals Inc. Surges 54% Yet Its Low P/S Is No Reason For Excitement

Analyst ratings

63%

of 19 ratings
Buy
63.2%
Hold
31.6%
Sell
5.3%

People also own

Based on the portfolios of people who own ACAD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.